AzTrials
AzTrials

GallstonesPhase 2NCT02947256

Laparoscopic Cholecystectomy With Retro-infundibular Approach

A Phase 2 study testing standard laparoscopic cholecystectomy and RI approach in people with Gallstones, run by Minia University at 2 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aimed to evaluate laparoscopic cholecystectomy by retro-infundibular (RI) approach compared to standard laparoscopic cholecystectomy (SLC) in difficult cases with scarred chole-cystohepatic (Calot's) triangle. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Gallstones
What is being tested?
standard laparoscopic cholecystectomy and RI approach
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
125 participants
Where
2 sitesEgypt
Study dates
Jul 2013to Jan 2016
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patient with gallstones
  • score difficulty according to Gupta et al 2013 > 6
  • patient fit for laparoscopic surgery

Who cannot join

  • score difficulty according to Gupta et al 2013 > 6
  • patient unfit for laparoscopic surgery
  • refusal to share in the study

Trial locations and contacts

2 sites in 1 country.

Egypt2 sites
  • Faculty of medicine

    Minya, 61511

  • Minia University Hospital

    Minya, 61511

Other trials in Egypt

About this study

Official title: Laparoscopic Cholecystectomy With Retro-infundibular Approach Versus Standard Laparoscopic Cholecystectomy in Difficult Cases, Where Calot's Triangle is Unsafe to be Dissected

Aimed to evaluate laparoscopic cholecystectomy by retro-infundibular (RI) approach compared to standard laparoscopic cholecystectomy (SLC) in difficult cases with scarred chole-cystohepatic (Calot's) triangle.

Read the detailed description

This study is a prospective cohort study, conducted in Minia university hospital and Minia insurance hospital in the period from July 2013 to January 2016, where 597 patients with gallstones were admitted for laparoscopic cholecystectomy and were done by the same surgeon. Based on the preoperative scoring system to predict the degree of difficulty in laparoscopic cholecystectomy, patients that had the score > 6 and were fit for laparoscopic surgery were included in the study. Only 125 met these criteria and agreed to share in the study and gave their informed consent. 60 patients were operated by SLC (Group 1).This included the classic dissection of Calot's triangle to achieve the CVS, with separate clipping and division of cystic duct and artery. While, 65 patients were operated by laparoscopic cholecystectomy using RI approach (Group 2). This included separation of the lower third of GB from its bed down to its pedicle (artery and duct) with mass ligation of both.

Operative procedure of by RI approach:

The site of trocars was the same as for the standard cholecystectomy. After dissection of adhesion masking the GB, if present, to reach the Hartmann pouch, at this point Calot's triangle usually was scarred and frozen, the surgeon never tried to dissect it and instead the surgeon continued as follow :

  1. De-shouldering of GB: by incising the serosal covering on either side of the infundibulum and lower part of the body.
  2. This followed by dissection and separation of the lower third of GB body from its bed, using suction-irrigation probe or hook dissector. Dissection continued downward till the GB pedicle (duct and artery).
  3. Mass ligation of cystic artery and duct, using intracorporeal note by vicryl number 1 suture.
  4. Then the surgeon cut above the ligature using diathermy on scissor or ultrasound sealing device. During this step the cut end of the GB was grasped by forceps trying to prevent spillage of its content, if happened, stones were collected in a bag and extracted.
  5. Then GB was dissected from its bed as usual and extracted in a bag. In cases where the GB was hugely distended, it was aspirated firstly to facilitate its grasping. Also in cases of Mirizzi syndrome the GB was opened direct on the stone to remove it, to facilitate grasping of GB then we continued as described above
Conditions
Gallstones
Being tested
standard laparoscopic cholecystectomy, RI approach
Medical subject headings
Gallstones

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • standard laparoscopic cholecystectomyProcedure or surgery

    Also called SLC

    which included the classic dissection of Calot's triangle to achieve the CVS, with separate clipping and division of cystic duct and artery

  • RI approachProcedure or surgery

    which included separation of the lower third of GB from its bed down to its pedicle (artery and duct) with mass ligation of both.

Study groups in NCT02947256
Study groupRoleWhat they receive
standard laparoscopic cholecystectomyActive comparatorThis included the classic dissection of Calot's triangle to achieve the CVS, with separate clipping and division of cystic duct and artery.
Receives: Procedure: standard laparoscopic cholecystectomy
RI approachExperimentalRetroinfundibular laparoscopic cholecystectomy: This included separation of the lower third of GB from its bed down to its pedicle (artery and duct) with mass ligation of both. Operative procedure of by RI approach:
Receives: Procedure: RI approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. conversion to open

    the incidence of conversion to open

    Measured: 24 hours

  2. biliary injury

    the incidence of biliary injury

    Measured: 2 weeks

Secondary outcomes (3)
  1. operative time

    time from skin opening to skin closure

    Measured: 24 hours

  2. hospital stay

    time of hospital stay

    Measured: 6 weeks

  3. mortality

    incidence of operative related mortality

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2016 (estimated)
  2. Study startJul 2013
  3. Primary completionJan 2016
  4. Study completionJan 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
125 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02947256
Sponsor's protocol ID
fac.med.011
Status last verified
Oct 2016
First submitted
22 Oct 2016
Last updated
1 Nov 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing standard laparoscopic cholecystectomy and RI approach in people with Gallstones, run by Minia University at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

conversion to open (time frame: 24 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in